Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients
Färber, L.; Maibücher, A.; Geissler, F.; Gutzler, F.; Wiesinger, F.O.; Winkler, M.
Transplantation Proceedings 26(5): 2988-2993
1994
ISSN/ISBN: 0041-1345 PMID: 7940944 Document Number: 427600
Document emailed within 1 workday
Related Documents
Tsang, W.K.; Ho, Y.W.; Tong, K.L.; Chan, W.H.; Chan, A. 1996: Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients Transplantation Proceedings 28(3): 1330-1332Min, Z.L.; Zhao, M.; Zhu, Y.H.; Qi, J.; Wang, L.M.; Wang, Y.W. 1996: Experience with clinical use of Sandimmun Neoral in renal transplant patients Transplantation Proceedings 28(3): 1356-1357
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233
Neumayer, H.H.; Färber, L.; Haller, P.; Kohnen, R.; Maibücher, A.; Schuster, A.; Vollmar, J.; Waiser, J. 1994: Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month Transplantation Proceedings 26(5): 2944-2948
Pethig, K.; Geiger, M.; Korn, A.; Grote, M.; Christians, U.; Wahlers, T. 1996: Follow-up after conversion to Neoral in stable heart transplant recipients Transplantation Proceedings 28(4): 2282-2284
Atkison, P.R.; Grant, D.R.; Williams, S.E.; Howard, J.; Wall, W.J.; Stiller, C.R. 1994: Sandimmune Neoral in paediatric liver transplant recipients with malabsorption of cyclosporin a Transplantation Proceedings 26(5): 2953-2954
Taesch, S.; Niese, D.; Mueller, E.A. 1994: Sandimmun neoral, a new oral formulation of cyclosporin a with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients Transplantation Proceedings 26(6): 3147-3149
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Massari, P.U.; Grosso, S.; de Boccardo, G.; Vásquez, M.C.; Schiavelli, R.O.; Sabbatiello, R.R.; Casadei, D.H.; Rial, M.C.; Jost, L.J.; Túrin, M.D.; Agost Carreño C, A.; Maggiora, E.C.; Gadea, M.M. 1996: A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group Transplantation Proceedings 28(6): 3365-3367
Dotti, G.; Gaspari, F.; Caruso, R.; Perico, N.; Remuzzi, G.; Barbui, T.; Rambaldi, A. 2001: Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients Haematologica 86(3): 311-315
Trull, A.; Hue, K.; Tan, K.; Gore, S.; Whitewood, S.; Smyth, R.; Scott, J.; Price, C.; Wallwork, J. 1990: Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients Clinical Chemistry 36(8 Part 1): 1474-1478
Magelli, C.; Magnani, G.; Grigioni, F.; Coccolo, F.; Potena, L.; Leone, O.; Magnani, B. 2003: Clinical problems in heart transplant recipients Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 4(4): 277-298
Holt, D.W.; Mueller, E.A.; Kovarik, J.M.; van Bree, J.B.; Richard, F.; Kutz, K. 1995: Sandimmun neoral pharmacokinetics: impact of the new oral formulation Transplantation Proceedings 27(1): 1434-1437
Gajarski, R.J.; Smith, E.O.; Denfield, S.W.; Rosenblatt, H.M.; Kearney, D.; Frazier, O.H.; Radovancevic, B.; Price, J.K.; Kertesz, N.J.; Towbin, J.A. 1998: Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients Transplantation 65(11): 1470-1476
Levy, G.A. 1996: Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral Transplantation Proceedings 28(4): 2252-2253
Babarykin, D.; Amerika, D.; Adamsone, I.; Valinietse, M.; Rosental, R. 1996: Transfer of patients with kidney grafts to Sandimmun Neoral normalizes the calcium level in erythrocyts Transplantation Proceedings 28(6): 3137
Moreno, J.; Montero, J.L.; Gavilán, F.; Costán, G.; Herrero, C.; Cárdenas, M.; Sánchez-Guijo, P.; Torre-Cisneros, J. 1999: Open clinical trial with oral acyclovir for the prophylaxis of disease by Cytomegalovirus in low risk liver transplant recipients Enfermedades Infecciosas y Microbiologia Clinica 17(8): 382-385
Lim, T.T.; Botas, J.; Ross, H.; Liang, D.H.; Theodore, J.; Hunt, S.A.; Oesterle, S.N.; Yeung, A.C. 1996: Are heart-lung transplant recipients protected from developing transplant coronary artery disease? A case-matched intracoronary ultrasound study Circulation 94(7): 1573-1577
Zakliczyński, M.ł; Lekston, A.; Swierad, M.; Wnek, A.; Buszman, P.ł; Przybylski, R.; Wojarski, J.; Przybylski, J.; Foremny, J.; Poloński, L.; Zembala, M. 2003: Coronary artery disease in heart transplant recipients - diagnosis and treatment. Single centre experience based on results of elective coronary angiography Kardiologia Polska 58(2): 109-120
Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873